Nasdaq Biotechnology Ishares ETF (IBB)

$141.30 +1.07 (0.76%)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 552,023
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts N/A
Price Target N/A

Company Profile

The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.

Phone: 1-800-474-2737
JFDI
JFDI Jul. 13 at 7:04 PM
$IBB
0 · Reply
SteveJohnsonis
SteveJohnsonis Jul. 13 at 11:03 AM
$IBB $MRNA $XBI
0 · Reply
QuantLake
QuantLake Jul. 13 at 10:04 AM
Bitcoin ETF Jumps 4.2% as Biotech Declines - Friday What Happened: iShares Bitcoin $IBIT +4.2% VanEck Gold Miners $GDX +1% iShares Global Clean Energy $ICLN -1.33% iShares Biotechnology $IBB -1.54% Our Take: $IBIT: Bullish Momentum - Positive Sentiment. $GDX: Bullish Momentum - Positive Sentiment. $ICLN: Bullish Momentum - Neutral Sentiment. $IBB: Neutral Momentum - Neutral Sentiment.
0 · Reply
bestonlinetrades_com
bestonlinetrades_com Jul. 12 at 7:57 PM
$MYNZ $IBB $XBI MYNZ is going to save the world !!!! The market cap of any biotech stock that has at least a 5% chance to eliminate colon cancer should be 100 million to 1 billion dollars, just on the potential of achieving that ! https://youtu.be/jW8o8RhoKU0?si=i0bCifs_HuJAxS_Y
1 · Reply
BioRich
BioRich Jul. 12 at 2:17 PM
$CAPR will get approved, will just take a bit longer. The data is excellent and hasn't drawn concern from the FDA. I believe the FDA gifted CAPR an early CRL so they can work towards resolution. This is monumental. Historically, FDA would have issued the CRL at the PDUFA data (late August, I believe) and leave the company to fend for itself. This appears the FDA is handholding CAPR through the process, almost admitting they (FDA) messed up and giving CAPR every possible chance for success. I think the additional data is able to provide with this additional time will benefit them substantially and help build their relationship with the FDA. For these and so many other reasons, I'm 100% confident CAPR gets approved, just going to take a little longer than expected (because of the FDA, not CAPR). Follow/Subscribe for more suggestions and perspective. Would love to hear yours too. That's how we find these gems and learn. Let's make some money. Cheers! $XBI $IBB
4 · Reply
BioRich
BioRich Jul. 12 at 4:31 AM
$ALT @Jacked_Nicholson @Popeye989 While simple minds focus on the Sentiment button, sophisticated minds focus on content. I have shared explanations for every post I've made about $ALT over the past year and a half. 99% of them were negative. Recent Bullish posts were related to $ALT's potential for SP improvement from the unknown potentially positive effect of using AI data to support fibrosis improvement. Not resting on hopium, I researched further (as I've consistently done) and found that the AI hope was far less impressive as the company didn't present AI data for Fibrosis that would support their claims. Furthermore, additional analysis of presented data showed ALT failed their MASH P2b trial in the primary focus (fibrosis improvement) worse than the data they highlighted that still dropped SP 60%. So sure, I've posted positives and negatives. I've tabbed Bearish (mostly) and Bullish. I believe it's a sign of continued research and not stagnant hope. Cheers! $XBI $CAPR $IBB
1 · Reply
BIOTECH_GURU
BIOTECH_GURU Jul. 12 at 4:26 AM
$XBI $IBB THE BIOTECH INDUSTRY WILL LIKELY SEE THE GREATEST BULL MARKET SINCE THE POST PANDEMIC SURGE. IT WILL BE SPARKED BY RATE CUTS. SOON! MARK THIS POST. NFA GLA.
0 · Reply
ProKnifeCatcher87
ProKnifeCatcher87 Jul. 11 at 11:31 PM
$REGN $1,750 fv.., pipeline $IBB
0 · Reply
Honeystocks
Honeystocks Jul. 11 at 10:06 PM
$MRNA - I've been shitting on the Moderna stock for years. After a 95% haircut it might be putting in some kind of tradeable low despite the plummeting revenue and negative sentiment toward their lets speed up death covid products. How do you see it? $XBI $IBB
2 · Reply
jaydilks
jaydilks Jul. 11 at 9:13 PM
$DNA Not a great day for Biotech. Last 3 months are in an uptrend with DNA showing higher Beta of higher highs and lower lows. The trend is still up for all of them. $XBI $IBB are great ways to have exposure. DNA is the tip of the spear for most washed out and now recovering.
0 · Reply
Latest News on IBB
Heard on the Street: Why pharma stocks have outperformed the broader market since Trump threatened the industry with a 200% tariff

Jul 13, 2025, 7:01 AM EDT - 12 hours ago

Heard on the Street: Why pharma stocks have outperformed the broader market since Trump threatened the industry with a 200% tariff

XLV

Trump threatens 50% tariffs on copper, 200% on pharmaceuticals

Jul 9, 2025, 11:09 AM EDT - 4 days ago

Trump threatens 50% tariffs on copper, 200% on pharmaceuticals

CPER XBI

Biotech Looks Ready To Run, But ETFs, Which One? IBB Vs. XBI

Jul 6, 2025, 11:12 AM EDT - 7 days ago

Biotech Looks Ready To Run, But ETFs, Which One? IBB Vs. XBI

XBI

5 Stocks I'm Buying As The 'Big Beautiful Bill' Pushes The Market To New Highs

Jul 5, 2025, 8:05 AM EDT - 8 days ago

5 Stocks I'm Buying As The 'Big Beautiful Bill' Pushes The Market To New Highs

ACHC AMH ARE CHAT COLD ELS FSLR

Fast Money: WTI, IBB, UBER, CAT

Jun 13, 2025, 6:20 PM EDT - 4 weeks ago

Fast Money: WTI, IBB, UBER, CAT

UBER CAT

Healthcare Sector Checkup As U.S. Looks To Change Regulations

May 30, 2025, 3:30 PM EDT - 6 weeks ago

Healthcare Sector Checkup As U.S. Looks To Change Regulations

AGNG ARKG BBC BBH BBP BIB BIS

IBB: Now Is The Time To Be Contrarian

May 29, 2025, 10:59 AM EDT - 6 weeks ago

IBB: Now Is The Time To Be Contrarian

Jefferies' Michael Yee: Drug discovery could be one of the biggest beneficiaries of generative AI

May 28, 2025, 12:22 PM EDT - 6 weeks ago

Jefferies' Michael Yee: Drug discovery could be one of the biggest beneficiaries of generative AI

AMGN BIIB DHR GILD ILMN NVS SDGR

Trump is right about drug prices. He's just going about it all wrong.

May 13, 2025, 1:43 PM EDT - 2 months ago

Trump is right about drug prices. He's just going about it all wrong.

XBI XLV

New vaccine chief rocks pharmaceutical stocks

May 7, 2025, 11:13 AM EDT - 2 months ago

New vaccine chief rocks pharmaceutical stocks

BNTX MRNA NVAX PFE GSK SRPT XBI

Trump Says Pharmaceutical Tariffs Coming in Near Future

Apr 14, 2025, 2:03 PM EDT - 3 months ago

Trump Says Pharmaceutical Tariffs Coming in Near Future

ABBV AMGN AZN BMY GSK JNJ LLY

Sell into strength in pharma, says Mizuho's Jared Holz

Apr 11, 2025, 7:17 PM EDT - 3 months ago

Sell into strength in pharma, says Mizuho's Jared Holz

XBI

Trump's pharmaceutical tariffs could raise costs for patients, worsen drug shortages

Apr 11, 2025, 10:30 AM EDT - 3 months ago

Trump's pharmaceutical tariffs could raise costs for patients, worsen drug shortages

ABBV AMGN AZN BMY GSK JNJ LLY

How to Play the Biotech Meltdown in the Age of RFK Jr. and Tariffs

Apr 11, 2025, 5:30 AM EDT - 3 months ago

How to Play the Biotech Meltdown in the Age of RFK Jr. and Tariffs

XBI

BMO's Siegerman talks the impact of tariffs on pharmaceutical stocks

Apr 9, 2025, 6:32 PM EDT - 3 months ago

BMO's Siegerman talks the impact of tariffs on pharmaceutical stocks

ABBV AMGN AZN BMY GSK JNJ LLY

Explainer: Prescription drugs become a target in Trump's trade war

Apr 9, 2025, 2:27 PM EDT - 3 months ago

Explainer: Prescription drugs become a target in Trump's trade war

ABBV AMGN AZN BMY GSK JNJ LLY

Healthy Returns: Trump says major pharmaceutical tariffs coming ‘very shortly'

Apr 9, 2025, 1:06 PM EDT - 3 months ago

Healthy Returns: Trump says major pharmaceutical tariffs coming ‘very shortly'

ABBV AMGN AZN BMY GSK JNJ LLY

Why drug stocks are no longer a safe haven from the stock market's turmoil

Apr 9, 2025, 11:49 AM EDT - 3 months ago

Why drug stocks are no longer a safe haven from the stock market's turmoil

ABBV AMGN BMY JNJ LLY MRK PFE

Invest In A New Biotech Bull Market With XBI And IBB

Mar 2, 2025, 8:33 AM EST - 4 months ago

Invest In A New Biotech Bull Market With XBI And IBB

XBI

Seeking Stocks With Vitality In The Volatile Healthcare Sector

Feb 25, 2025, 11:06 AM EST - 4 months ago

Seeking Stocks With Vitality In The Volatile Healthcare Sector

XLV AGNG ARKG BBC BBH BBP BIB

How tariffs could impact pharma and early-stage healthcare investments

Feb 3, 2025, 6:43 PM EST - 5 months ago

How tariffs could impact pharma and early-stage healthcare investments

XLV

Biotech walks a 'tightrope' amid unclear funding, regulations

Jan 30, 2025, 7:06 PM EST - 5 months ago

Biotech walks a 'tightrope' amid unclear funding, regulations

DCTH ELVN

Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025

Jan 13, 2025, 6:10 PM EST - 6 months ago

Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025

ABBV AMGN AZN BNTX FBCG GILD GSK

iShares Biotechnology ETF: Playing Defense

Dec 10, 2024, 1:33 PM EST - 7 months ago

iShares Biotechnology ETF: Playing Defense

Mizuho's Jared Holz on what Trump's FDA pick means for biotech innovation

Nov 25, 2024, 6:44 PM EST - 8 months ago

Mizuho's Jared Holz on what Trump's FDA pick means for biotech innovation

HIMS LLY MRNA NVO PFE

Health care stocks jump on Trump's nominee for FDA head

Nov 25, 2024, 6:22 PM EST - 8 months ago

Health care stocks jump on Trump's nominee for FDA head

HIMS LFMD MRNA PFE

Final Trade: Euro, IBB, SMH, NEM

Nov 20, 2024, 6:21 PM EST - 8 months ago

Final Trade: Euro, IBB, SMH, NEM

SMH NEM

Final Trade: West Pharma, Cameco, iShares Biotechnology ETF and Applied Digital Corp

Nov 15, 2024, 6:54 PM EST - 8 months ago

Final Trade: West Pharma, Cameco, iShares Biotechnology ETF and Applied Digital Corp

APLD CCJ WST

IBB: A Near-20x P/E Is Historically Pricey, Technical Trends Neutral

Oct 14, 2024, 7:36 AM EDT - 9 months ago

IBB: A Near-20x P/E Is Historically Pricey, Technical Trends Neutral

Biotech Stocks Are Showing Signs of Life. Why the Rally Could Continue.

Aug 30, 2024, 5:34 PM EDT - 11 months ago

Biotech Stocks Are Showing Signs of Life. Why the Rally Could Continue.

GILD XBI

Biotech stocks will get a tailwind from rate cuts, says Stempoint's Michelle Ross

Aug 12, 2024, 4:25 PM EDT - 11 months ago

Biotech stocks will get a tailwind from rate cuts, says Stempoint's Michelle Ross

LLY XBI

Analyst is 'extremely bullish' on biopharma

Jul 30, 2024, 3:25 PM EDT - 1 year ago

Analyst is 'extremely bullish' on biopharma

MRK PFE

iShares Biotechnology ETF: Significant Upside Potential As Sector Gains Momentum

Jul 28, 2024, 12:25 PM EDT - 1 year ago

iShares Biotechnology ETF: Significant Upside Potential As Sector Gains Momentum

Biotech Stocks 2024 Second Half Outlook - Buy Biotechs

Jul 9, 2024, 7:00 AM EDT - 1 year ago

Biotech Stocks 2024 Second Half Outlook - Buy Biotechs

XBI

For Biotech Stocks To Move Higher, This Must Move Lower

May 13, 2024, 9:00 AM EDT - 1 year ago

For Biotech Stocks To Move Higher, This Must Move Lower

XBI

This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?

Apr 10, 2024, 9:27 AM EDT - 1 year ago

This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?

AMGN ASND CYTK DXCM EW HRTS IHE

Biotech's Next Gold Rush: Weight-Loss Drugs

Apr 2, 2024, 4:56 PM EDT - 1 year ago

Biotech's Next Gold Rush: Weight-Loss Drugs

LLY NVO

Catch The Medical Breakthroughs With The IBB ETF

Mar 28, 2024, 2:01 AM EDT - 1 year ago

Catch The Medical Breakthroughs With The IBB ETF

IBB: Let It Rest

Mar 26, 2024, 4:46 AM EDT - 1 year ago

IBB: Let It Rest

Why Biotech Stocks May Be Ready For A Recovery

Mar 9, 2024, 3:59 AM EST - 1 year ago

Why Biotech Stocks May Be Ready For A Recovery

BBH XLV

Navigating the big run in biotech

Feb 15, 2024, 1:44 PM EST - 1 year ago

Navigating the big run in biotech

XBI

Health care's underperformance last year sets it up well for 2024, says Mara Goldstein

Feb 8, 2024, 7:34 AM EST - 1 year ago

Health care's underperformance last year sets it up well for 2024, says Mara Goldstein

XLV

Healthcare In 2024: Navigating The Biopharma Bull Run

Jan 17, 2024, 11:22 PM EST - 1 year ago

Healthcare In 2024: Navigating The Biopharma Bull Run

FHLC IYH PPH VHT XBI XLV

Equity CEFs/ETFs: Top Picks For 2024 - Part II

Jan 5, 2024, 11:01 AM EST - 1 year ago

Equity CEFs/ETFs: Top Picks For 2024 - Part II

AIO AIQ BIB DIG EOI ETW EXG

Dr. Scott Gottlieb talks Big Pharma's buying spree

Dec 27, 2023, 4:26 PM EST - 1 year ago

Dr. Scott Gottlieb talks Big Pharma's buying spree

XBI

Wedbush's Laura Chico talks biotech investing in 2024

Dec 26, 2023, 5:21 PM EST - 1 year ago

Wedbush's Laura Chico talks biotech investing in 2024

EWTX NBIX VRDN XBI

Buy or bail on biotech: Here's what you need to know

Dec 26, 2023, 1:40 PM EST - 1 year ago

Buy or bail on biotech: Here's what you need to know

XBI

JFDI
JFDI Jul. 13 at 7:04 PM
$IBB
0 · Reply
SteveJohnsonis
SteveJohnsonis Jul. 13 at 11:03 AM
$IBB $MRNA $XBI
0 · Reply
QuantLake
QuantLake Jul. 13 at 10:04 AM
Bitcoin ETF Jumps 4.2% as Biotech Declines - Friday What Happened: iShares Bitcoin $IBIT +4.2% VanEck Gold Miners $GDX +1% iShares Global Clean Energy $ICLN -1.33% iShares Biotechnology $IBB -1.54% Our Take: $IBIT: Bullish Momentum - Positive Sentiment. $GDX: Bullish Momentum - Positive Sentiment. $ICLN: Bullish Momentum - Neutral Sentiment. $IBB: Neutral Momentum - Neutral Sentiment.
0 · Reply
bestonlinetrades_com
bestonlinetrades_com Jul. 12 at 7:57 PM
$MYNZ $IBB $XBI MYNZ is going to save the world !!!! The market cap of any biotech stock that has at least a 5% chance to eliminate colon cancer should be 100 million to 1 billion dollars, just on the potential of achieving that ! https://youtu.be/jW8o8RhoKU0?si=i0bCifs_HuJAxS_Y
1 · Reply
BioRich
BioRich Jul. 12 at 2:17 PM
$CAPR will get approved, will just take a bit longer. The data is excellent and hasn't drawn concern from the FDA. I believe the FDA gifted CAPR an early CRL so they can work towards resolution. This is monumental. Historically, FDA would have issued the CRL at the PDUFA data (late August, I believe) and leave the company to fend for itself. This appears the FDA is handholding CAPR through the process, almost admitting they (FDA) messed up and giving CAPR every possible chance for success. I think the additional data is able to provide with this additional time will benefit them substantially and help build their relationship with the FDA. For these and so many other reasons, I'm 100% confident CAPR gets approved, just going to take a little longer than expected (because of the FDA, not CAPR). Follow/Subscribe for more suggestions and perspective. Would love to hear yours too. That's how we find these gems and learn. Let's make some money. Cheers! $XBI $IBB
4 · Reply
BioRich
BioRich Jul. 12 at 4:31 AM
$ALT @Jacked_Nicholson @Popeye989 While simple minds focus on the Sentiment button, sophisticated minds focus on content. I have shared explanations for every post I've made about $ALT over the past year and a half. 99% of them were negative. Recent Bullish posts were related to $ALT's potential for SP improvement from the unknown potentially positive effect of using AI data to support fibrosis improvement. Not resting on hopium, I researched further (as I've consistently done) and found that the AI hope was far less impressive as the company didn't present AI data for Fibrosis that would support their claims. Furthermore, additional analysis of presented data showed ALT failed their MASH P2b trial in the primary focus (fibrosis improvement) worse than the data they highlighted that still dropped SP 60%. So sure, I've posted positives and negatives. I've tabbed Bearish (mostly) and Bullish. I believe it's a sign of continued research and not stagnant hope. Cheers! $XBI $CAPR $IBB
1 · Reply
BIOTECH_GURU
BIOTECH_GURU Jul. 12 at 4:26 AM
$XBI $IBB THE BIOTECH INDUSTRY WILL LIKELY SEE THE GREATEST BULL MARKET SINCE THE POST PANDEMIC SURGE. IT WILL BE SPARKED BY RATE CUTS. SOON! MARK THIS POST. NFA GLA.
0 · Reply
ProKnifeCatcher87
ProKnifeCatcher87 Jul. 11 at 11:31 PM
$REGN $1,750 fv.., pipeline $IBB
0 · Reply
Honeystocks
Honeystocks Jul. 11 at 10:06 PM
$MRNA - I've been shitting on the Moderna stock for years. After a 95% haircut it might be putting in some kind of tradeable low despite the plummeting revenue and negative sentiment toward their lets speed up death covid products. How do you see it? $XBI $IBB
2 · Reply
jaydilks
jaydilks Jul. 11 at 9:13 PM
$DNA Not a great day for Biotech. Last 3 months are in an uptrend with DNA showing higher Beta of higher highs and lower lows. The trend is still up for all of them. $XBI $IBB are great ways to have exposure. DNA is the tip of the spear for most washed out and now recovering.
0 · Reply
QuantLake
QuantLake Jul. 11 at 1:27 PM
Bitcoin ETF Gains 1.45% as Tech Dips - Thursday Market Summary: iShares Bitcoin $IBIT rose +1.45% iShares Biotechnology $IBB gained +1.03% iShares U.S. Technology $IYW fell -0.33% iShares Global Clean Energy $ICLN dropped -0.37% Our Data Points To: $IBIT: Bullish Momentum - Positive Sentiment. $IBB: Neutral Momentum - Neutral Sentiment. $IYW: Bullish Momentum - Positive Sentiment. $ICLN: Bullish Momentum - Positive Sentiment.
0 · Reply
bestonlinetrades_com
bestonlinetrades_com Jul. 11 at 2:53 AM
$MYNZ $IBB $XBI Mynz is going to double digits. Keep the big picture in mind. MONTHLY RSI along with moving average. Soon to cross bullish.
0 · Reply
lextrading
lextrading Jul. 10 at 3:05 PM
$IBB It was April 25th when I shared this bullish engulfing weekly candle off the long-term support. Always take a long-term view.
0 · Reply
QuantLake
QuantLake Jul. 10 at 12:42 PM
Bitcoin ETF Leads with 2.85% Gain - Wednesday Daily Snapshot: iShares Bitcoin $IBIT surged +2.85% iShares Biotechnology $IBB climbed +2.29% Global X NASDAQ 100 Covered Call $QYLD flat 0% First Trust Long/Short Equity $FTLS slipped -0.09% Our Perspective: $IBIT: Bullish Momentum - Positive Sentiment. $IBB: Neutral Momentum - Neutral Sentiment. $QYLD: Bullish Momentum - Neutral Sentiment. $FTLS: Bullish Momentum - Neutral Sentiment.
0 · Reply
JFDI
JFDI Jul. 10 at 11:36 AM
While RFK goin after dirty needles, we poppin pills. I hear we short on adhd meds. This true? $XBI $IBB
0 · Reply
thinkandpick
thinkandpick Jul. 10 at 6:40 AM
$FONR $LABU $IBB $XBI Healthcare sector. Fonar (FONR) just received a buyout proposal. On that front, RadNet $RDNT and $FONR are in the same industry (imaging centers). RDNT's Enterprise Value currently is about 3 times its Revenue and about 20 times its adj. EBITDA. FONR's Enterprise Value currently is about 0.5 times its Revenue and about 3 times its adj. EBITDA. On top of this, RDNT is indebted, while FONR is debt-free and cash-rich. This is one of many facts proving why it's robbery, if FONR is acquired under $25 per share: https://www.newsfilecorp.com/release/258308/FONAR-Board-of-Directors-Announces-Receipt-of-NonBinding-Take-Private-Proposal
0 · Reply
TalkMarkets
TalkMarkets Jul. 9 at 10:50 PM
A Big Piece Of The BBB Puzzle - Lower Interest Rates $TLT Also $IBB $QQQ $SPY $XRT https://talkmarkets.com/content/us-markets/a-big-piece-of-the-bbb-puzzle-lower-interest-rates?post=508385
0 · Reply
l4ndsh4rk
l4ndsh4rk Jul. 9 at 4:37 PM
$IBB $XBI So breaking out
0 · Reply
bestonlinetrades_com
bestonlinetrades_com Jul. 9 at 2:45 PM
$MYNZ $IBB $XBI what market cap would you assign to a biotech company preparing to eliminate colon cancer ? 100 million? 1 Billion 10 Billion 50 Billion ?????
2 · Reply
bestonlinetrades_com
bestonlinetrades_com Jul. 9 at 1:35 PM
$MYNZ $IBB $XBI IBB biotech index is on fire ! up 2% at the opening gate. MYNZ about to break north of RSI downtrendline ! look out above !
0 · Reply
QuantLake
QuantLake Jul. 9 at 12:03 PM
Semiconductor ETF Gains 1.33% as Gold Miners Retreat - Tuesday Market Moves: VanEck Semiconductor $SMH rose +1.33% iShares Biotechnology $IBB gained +0.94% iShares MSCI USA Momentum Factor $MTUM fell -0.9% VanEck Gold Miners $GDX dropped -4.48% Our View: $SMH: Bullish Momentum - Positive Sentiment. $IBB: Neutral Momentum - Neutral Sentiment. $MTUM: Bullish Momentum - Positive Sentiment. $GDX: Bullish Momentum - Positive Sentiment.
0 · Reply
US_Bull
US_Bull Jul. 9 at 9:39 AM
$AUPH $XBI $IBB Merck buys out Verona for 10 billion.
1 · Reply